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Abstract
Like other arthropod-borne viruses (arboviruses), mosquito-borne dengue virus (DENV) is maintained in an alternating cycle
of replication in arthropod and vertebrate hosts. The trade-off hypothesis suggests that this alternation constrains DENV
evolution because a fitness increase in one host usually diminishes fitness in the other. Moreover, the hypothesis predicts
that releasing DENV from host alternation should facilitate adaptation. To test this prediction, DENV was serially passaged in
either a single human cell line (Huh-7), a single mosquito cell line (C6/36), or in alternating passages between Huh-7 and C6/
36 cells. After 10 passages, consensus mutations were identified and fitness was assayed by evaluating replication kinetics in
both cell types as well as in a novel cell type (Vero) that was not utilized in any of the passage series. Viruses allowed to
specialize in single host cell types exhibited fitness gains in the cell type in which they were passaged, but fitness losses in
the bypassed cell type, and most alternating passages, exhibited fitness gains in both cell types. Interestingly, fitness gains
were observed in the alternately passaged, cloned viruses, an observation that may be attributed to the acquisition of both
host cell–specific and amphi-cell-specific adaptations or to recovery from the fitness losses due to the genetic bottleneck of
biological cloning. Amino acid changes common to both passage series suggested convergent evolution to replication in
cell culture via positive selection. However, intriguingly, mutations accumulated more rapidly in viruses passed in Huh-7
cells than in those passed in C6/36 cells or in alternation. These results support the hypothesis that releasing DENV from
host alternation facilitates adaptation, but there is limited support for the hypothesis that such alternation necessitates a
fitness trade-off. Moreover, these findings suggest that patterns of genetic evolution may differ between viruses replicating
in mammalian and mosquito cells.
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Introduction
Arthropod-borne RNA viruses (arboviruses) pose an especially
high risk of emergence from reservoir hosts into humans [1,2], due
to the genetic plasticity of the viral RNA genome coupled with the
dispersal potential of arthropod vectors and some amplification
hosts. Paradoxically, vector-borne RNA viruses undergo substan-
tially slower rates of evolution (by a factor of ten) than many of
their directly-transmitted counterparts [3,4,5]. To explain this
disparity, the trade-off hypothesis postulates that alternating
replication in vertebrate and arthropod hosts constrains arbovirus
evolution, because a fitness increase in one host usually diminishes
fitness in the other.
Experimental evolution in vivo has been a valuable approach for
testing this hypothesis. In particular, it has been illuminating to
compare the evolution of viruses that have been serially passaged
in a single host versus viruses passaged in alternation between two
different hosts. For example, Ross River Virus, an alphavirus,
showed phenotypic stability during alternating passages in Aedes
aegypti mosquitoes and mice but increased in neurovirulence after
serial passage in mouse brains, suggesting that host alternation
restrains the evolution of virulence [6,7]. Similarly, in another
alphavirus, Venezuelan equine encephalitis (VEEV), lineages
passaged 10 times in Ae. aegypti exhibited an increase in mosquito
infectivity relative to viruses passaged in alternation between
rodents and mosquitoes, while rodent-specialized strains produced
higher viremias in rodents relative to alternately-passaged virus.
Moreover both serially-passaged VEEV lines exhibited fitness
declines in the bypassed host, while lineages passaged in
mosquitoes and rodents in alternation demonstrated no detectable
fitness gains, or losses, in either mosquitoes or vertebrates [8].
Experimental evolution in vitro, while subject to particular
caveats discussed below, has also yielded valuable insights into the
constraints that shape arbovirus evolution. Studies of serially-
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adapted (specialized) viruses in the cell substrate used for passage,
and fitness losses in the bypassed cell line, as well as fitness gains in
most alternately passaged viruses [9]. Similar results were observed
with eastern equine encephalitis virus (EEEV) passaged in
mammalian and mosquito cell lines [10] or avian and mosquito
cell lines [11]. Surprisingly, EEEV passaged in alternation
increased in fitness in both cell types, in a manner similar to that
observed for single host-adapted viruses, but showed a lower rate
of mutation than single-host adapted viruses [11]. However,
studies with vesicular stomatitis virus (VSV) do not support the
hypothesis that alternating host replication imposes fitness trade-
offs, as symmetrical fitness increases were observed in both single
host-adapted (specialized) and alternate-passaged viruses [12].
Nonetheless, in another study VSV was allowed to specialize in a
vertebrate cell host [baby hamster kidney cells (BHK)] and it
exhibited substantial fitness gains for those cells but fitness declines
on novel host (HeLa or MDCK) cells [13].
Mosquito-borne dengue virus (DENV) offers an especially
interesting system in which to examine the trade-off hypothesis
for 3 major reasons. First, the 4 serotypes of endemic DENV that
circulate between humans and peridomestic Aedes mosquitoes are
known to have emerged in four independent events from sylvatic
progenitors that are maintained in non-human primates and
arboreal Aedes spp. [14]. Today, these endemic DENV lineages
are both ecologically and evolutionarily independent from the
ancestral sylvatic cycles. It is therefore possible to compare the
patterns of, and constraints on, the evolution of viral isolates from
both the ancestral and derived transmission cycles. Second,
phylogenetic studies indicate that the rate of evolution in endemic
DENV has accelerated substantially [3,15,16,17], probably driven
by the surge in transmission that has occurred over the last 50 years
[18]. Since there is neither a vaccine nor licensed antiviral therapy
available to control DENV spread, it is increasingly important to
gain insights into the factors that will shape its evolution as the
pandemic progresses. Finally, it is possible that DENV is under
selection for increasing virulence. Severe disease [dengue hemor-
rhagic fever/dengue shock syndrome (DHF/DSS)] was first
documented in the 1950’s and has dramatically increased in
frequency ever since [19,20,21,22]. While sequential infection by
two different DENV serotypes is a major risk factor for severe
disease [23,24,25,26,27], it has also been shown that individual
DENV strains and genotypes vary in their tendency to cause severe
disease [20,21,22,28,29,30,31]. Moreover, there are now several
examples of DENV strains associated with severe disease displacing
milder strains [32,33]. For example, extensive epidemiological and
phylogenetic evidence indicates that Southeast Asian DENV-2
genotypes are more likely to cause DHF/DSS than American or
South Pacific genotypes. After it was introduced into the Americas,
the Southeast Asian DENV-2 genotype began to displace the native
American genotype [34,35,36,37,38,39,40,41,42,43]. Studies of
DENV evolution could provide insight into the likelihood and
extent of shifts to higher virulence.
Three hypotheses were tested in the current study: (i) releasing
DENV from alternating host replication by repeated passages in a
single host facilitates adaptation to that host and results in an
increase in mutation accumulation; (ii) adaptation to a single host
is usually specific and results in fitness declines in other hosts; and
(iii) host alternation selects for virus populations that are
genetically conserved and show little or no adaptation to either
host. To test these hypotheses, one isolate of endemic and one
isolate of sylvatic DENV-2 were maintained in one of 3 serial
passage regimens: 10 passages in human vertebrate cells; 10
passages in mosquito cells, or 10 alternating passages between the
two cells lines (10 passages in each cycle; 20 passages total)
(Figure 1). In the absence of an established and practical in vivo
vertebrate model for studying DENV host range evolution, we
used the human hepatoma Huh-7 and Ae. albopictus C6/36 cell
lines as surrogate hosts for host range evolution. The rationale for
utilizing the Huh-7 cell line lies in the in vivo liver involvement in
DENV infection [44,45,46], and Ae. albopictus is an important
secondary DENV vector [18]. The fitness of each passaged series
was compared to that of other evolved lineages and to the parent
virus in both the cell lines used for passage, the bypassed cell line
and a novel cell line (African green monkey kidney Vero cells) that
was not utilized in any of the passage series. To assess the impact
of quasispecies diversity on patterns of adaptation, passages of
each strain were initiated separately, with either a cloned (plaque-
purified biological clone) virus that was genetically relatively
homogeneous or uncloned viruses that encompassed a more
diverse mutant spectrum. The definition and utility of the term
‘quasispecies’ has recently been questioned [47,48,49,50]. For the
purpose of our work, we define quasispecies as the intra-host viral
genetic variation that arises due to the high error rate of the viral
polymerase. Cloned viruses additionally allowed us to determine
whether cell-specific fitness gains in evolved viruses were likely the
result of specific mutations.
Results
One important consideration for studies of virus evolution in
vitro is that viruses may adapt to features of cultured cells that are
irrelevant in vivo, such as temperature [12,51], defective interfering
(DI) particles, or overexpression of heparan sulfate (HS)
[52,53,54]. To overcome the former two limitations, all infected
cell cultures were incubated at 32uC and a low multiplicity of
infection was maintained to minimize the evolution of defective
interfering particles. While it was not possible to influence the
expression of HS in the cells used, we utilized duplicate parallel
passage series for each treatment to assess variance in outcomes
Additionally, viral replication curves show inherent variability due
to: (i) the dependence of virus replication on inoculum titers, which
Author Summary
Dengue virus (DENV) is an arthropod-borne virus of
immense public health concern. Recent studies suggest
that the rate of DENV evolution has accelerated, as well as
the disease severity (virulence), most likely driven by the
increased transmission and selection by the vector, Aedes
aegypti, over the last 50 years. Despite the nearly global
impact of DENV, little is known about the forces that
influence its host range evolution, a deficiency confound-
ed by the absence of a practical vertebrate model. We
used vertebrate (Huh-7) and invertebrate (C6/36) cells lines
as surrogate hosts for studying DENV host range evolution.
Using genetically homogeneous or heterogeneous DENV
for serial passages (specialization) in either cell line, or
alternating passage, we demonstrated that (i) viruses
allowed to specialize in single host cells exhibited fitness
gains but fitness losses in the bypassed cell line; (ii) most
viruses passaged in alternating cycles exhibited detectable
fitness gains in both cell lines; (iii) amino acid changes
common in both passage series suggested convergent
evolution via positive selection; and (iv) there was limited
support that DENV evolution is constrained by alternate
host transmission and replication. These results provide
insights into the likelihood and extent of shifts towards
higher DENV virulence.
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mation of the cell-adapted (i.e. Huh-7) virus titer due to loss of the
ability to form visible plaques in the cell line where progeny virus
titer is evaluated (e.g. C6/36). Previous studies have used
competition assays with genetic markers to overcome this latter
limitation [8,9,10]. However the lack of an infectious clone for
sylvatic DENV-2 prevented the use of genetic markers. Instead,
focus-forming assays were used to detect expressed antigen on the
surface of infected cells minimizing the possibility for underesti-
mation of the cell-adapted virus titers.
Comparisons of fitness and general patterns of
adaptation
As described in the Methods section, the replication dynamics of
a given DENV population serially passaged in a single cell line was
compared only to the matched population passaged in alternation
and to the parent population, using a repeated measures analysis
of variance (rmANOVA). The rmANOVA compares the shape
and height of the replication curve, thereby incorporating both the
rate and maximum level of viral replication, hereafter referred to
as ‘‘fitness’’. The individual panels in Figures 2, 3, 4, and 5 show
the patterns of replication in each of these comparison groups
graphically, while Tables 1 and 2 summarize the statistical
comparisons of fitness. For example, the statistical comparison of
the replication curves shown in Figure 2A are represented in the
first column of Table 1.
Overall, the data from this study, which are described in detail
below, reveal several general trends in the adaptation of sylvatic
and endemic DENV during exclusive and alternating passage.
First, cloned viruses showed a decline in fitness relative to the
uncloned parent tested immediately following plaque purification.
Subsequently, cloned viruses passaged on any cell type showed a
dramatic gain in fitness in all cell types. In contrast, passage of
uncloned viruses in single cell type (Huh-7 or C6/36) resulted in
increased fitness in that cell type, and loss of fitness in the bypassed
cell type. Passage of the endemic virus in alternation did not affect
fitness in Huh-7 cells, but decreased fitness in C6/36 cells and in
Vero cells, a novel host cell. However passage of the sylvatic virus
in alternation had little effect on fitness in any cell type. Finally,
passage in Huh-7 cells reliably led to a decrease in fitness in Vero
cells, but passage in C6/36 resulted in variable changes in fitness
(increases and decreases) in Vero cells.
Fitness of viruses passaged in a vertebrate cell line serial
passage and alternating passage of uncloned DENV
In general, fitness changes of duplicate DENV-2 lineages were
similar to one another (Tables 1 and 2). Reading horizontally
across the top two rows, note the general lack of arrows (lack of
significance) for the comparison of the A and B replicates of a
given passage series. Exclusive passage in Huh-7 resulted in an
increase in fitness in this cell line, relative to the parent, of both the
sylvatic (P8-1407) and endemic (IQT-1950) strains. In contrast,
alternating passage, with the exception of uncloned sylvatic strain
P8-1407 P10-B), usually had no impact on fitness in Huh-7 cells
(Figures 2A, B; Table 1).
To determine whether increases in fitness in the cell line used
for passage (Huh-7 cells) came at the cost of decreased replication
in the bypassed cell lines, replication curves were also evaluated in
C6/36 cells. Fitness of both Huh-7-adapted endemic and sylvatic
DENV strains was significantly lower than those of the parents and
alternating passage viruses in C6/36 cells (Figures 2C, D),
indicating that adaptation was host cell-specific.
Figure 1. Experimental design for DENV in vitro adaptation studies. Sylvatic strain P8-1407 or endemic strain IQT-1950 were serially passaged
in vertebrate Huh-7 cells (left) or invertebrate C6/36 cells (Ae. albopictus cell line) (right) to artificially bypass one host, or alternately passaged (center)
to simulate natural transmission. The fitness of DENV derived from these passage series compared to parent viruses was determined by direct
replication comparison.
doi:10.1371/journal.ppat.1000467.g001
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for passage came at the cost of decreased replication in additional
cell lines, replication curves were also evaluated in a novel cell line,
Vero cells. Fitness of both Huh-7-adapted endemic and sylvatic
DENV strains was significantly lower than those of the parents and
alternately passage viruses in Vero cells (Figures 2E, F).
Interestingly, the fitness of the alternately passaged viruses was
also significantly lower than the parent virus in most lineages
(Figure 2E, F). These results, summarized in Table 1, also indicate
that adaptation was cell-specific.
Serial passage and alternating passage of cloned DENV
In general, relative to the parental viruses, both biologically
cloned DENV strains showed increases in fitness after either
Figure 2. Replication of Huh-7 – passaged uncloned DENV-2. (a) Huh-7 – passaged sylvatic P8-1407 DENV-2 on Huh-7 cells. (b) Huh-7 –
passaged endemic IQT-1950 DENV-2 on Huh-7 cells. (c) Huh-7 – passaged sylvatic P8-1407 DENV-2 on the bypassed cell line C6/36. (d) Huh-7 –
passaged endemic IQT-1950 DENV-2 on the bypassed cell line C6/36. (e) Huh-7 – passaged sylvatic P8-1407 DENV-2 on a control cell line (Vero). (f)
Huh-7 – passaged endemic IQT-1950 DENV-2 on a control cell line (Vero). Timepoint T=0 represents residual virus after washing.
doi:10.1371/journal.ppat.1000467.g002
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driven by the initial loss in fitness that followed generation of the
clonal populations: the cloned sylvatic parent’s fitness was
significantly less than the uncloned parent (Figure 2A) both 4
(5.5360.07 vs 4.260.03 log10 ffu/ml) and 6 days p.i. (5.7360.03
vs 4.4560.05 log10 ffu/ml) and similarly, the cloned sylvatic
parent’s fitness was less than that of its uncloned parent both 4
(5.7560.02 vs 3.2860.03 log10 ffu/ml) and 6 days p.i. (5.960.02
vs 4.1960.06 log10 ffu/ml) (Figure 2B). This significant reduction
of the cloned parent’s replication may be attributable to sequence
differences compared to the uncloned viruses, since the consensus
sequence (most common nucleotide at each position for the virus
population) of the initial cloned populations differed from the
uncloned populations (Table 3). Similar reductions in fitness of
Figure 3. Replication of Huh-7 – passaged cloned DENV-2. (a) Huh-7 – passaged sylvatic P8-1407 DENV-2 on Huh-7 cells. (b) Huh-7 – passaged
endemic IQT-1950 DENV-2 on Huh-7 cells. (c) Huh-7 – passaged sylvatic P8-1407 DENV-2 on the bypassed cell line C6/36. (d) Huh-7 – passaged
endemic IQT-1950 DENV-2 on the bypassed cell line C6/36. (e) Huh-7 – passaged sylvatic P8-1407 DENV-2 on a control cell line (Vero). (f) Huh-7 –
passaged endemic IQT-1950 DENV-2 on a control cell line (Vero). Timepoint T=0 represents residual virus after washing.
doi:10.1371/journal.ppat.1000467.g003
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reported for VSV [55].
Fitness of the cloned sylvatic and endemic strains passaged
exclusively in Huh-7 cells was significantly higher (P,0.001) than
those of the parent when their replication was evaluated in Huh-7
cells (Figures 3A, B). The fitness of both endemic and sylvatic
alternately passaged viruses was significantly higher than those of
their parents, and the overall fitness of the specialized and
alternately passaged viruses did not differ significantly. Similarly,
fitness in the bypassed C6/36 cell line of both alternately passaged
DENV-2 strains was significantly higher than for the parent virus,
although in the Huh-7 – specialized viruses fitness was significantly
lower than for the alternately passaged viruses (Figures 3C, D). In
Veros, a novel cell line, fitness of both endemic and sylvatic Huh-
Figure 4. Replication of C6/36 – passaged uncloned DENV-2. (a) C6/36 – passaged sylvatic P8-1407 DENV-2 on C6/36 cells. (b) C6/36 –
passaged endemic IQT-1950 DENV-2 on C6/36 cells. (c) C6/36 – passaged sylvatic P8-1407 DENV-2 on the bypassed cell line Huh-7. (d) C6/36 –
passaged endemic IQT-1950 DENV-2 on the bypassed cell line Huh-7. (e) C6/36 – passaged sylvatic P8-1407 DENV-2 on a control cell line (Vero). (f) C6/
36 – passaged endemic IQT-1950 DENV-2 on a control cell line (Vero). Timepoint T=0 represents residual virus after washing.
doi:10.1371/journal.ppat.1000467.g004
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alternately passaged lineages (Figure 3E, F). As summarized in
Table 1, biologically cloned viruses exhibited a different pattern of
adaptation than uncloned viruses, with adaptation showing a less
specialized pattern, a reflection of the inherent low fitness of the
cloned viruses.
Fitness of viruses passaged in mosquito cells serial and
alternating passage of uncloned DENV
In general, fitness of duplicate mosquito cell-specialized lineages
was similar (Table 2). Exclusive passage in C6/36 cells resulted in
an increase in fitness, relative to the parent, for the uncloned
isolates of both the sylvatic (P8-1407) and endemic (IQT-1950)
Figure 5. Replication of C6/36 – passaged cloned DENV-2. (a) C6/36 – passaged sylvatic P8-1407 DENV-2 on C6/36 cells. (b) C6/36 – passaged
endemic IQT-1950 DENV-2 on C6/36 cells. (c) C6/36 – passaged sylvatic P8-1407 DENV-2 on the bypassed cell line Huh-7. (d) C6/36 – passaged
endemic IQT-1950 DENV-2 on the bypassed cell line Huh-7. (e) C6/36 – passaged sylvatic P8-1407 DENV-2 on a control cell line (Vero). (f) C6/36 –
passaged endemic IQT-1950 DENV-2 on a control cell line (Vero). Timepoint T=0 represents residual virus after washing.
doi:10.1371/journal.ppat.1000467.g005
Evolution of Dengue Virus In Vitro
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increase in fitness, relative to the parent, for the uncloned isolates
of the sylvatic DENV strain (Figure 4A), and resulted in a decrease
in fitness for the endemic DENV strain (Figure 4B).
To determine whether increases in fitness in the cell line used
for passage came at the cost of decreased replication in other cell
lines, replication kinetics were also evaluated in the bypassed Huh-
7 and Vero cells. When their replication was evaluated in Huh-7
cells, fitness of both C6/36-adapted endemic and sylvatic DENV
strains was significantly lower than for the parents and alternately
passage viruses (Figure 4C, D). Both parent and alternately
passaged viruses had similar replication kinetics. Surprisingly,
when their replication was evaluated in Vero cells, fitness of the
C6/36-specialized sylvatic strain was significantly higher than that
of the parents; no fitness changes were observed for the alternating
passage viruses (Figure 4E). Fitness of the C6/36-adapted and
alternate passage endemic strain was significantly lower than for
the parent (Figure 4F). Overall, the data suggest that exclusive
passage of viruses in C6/36 cells improves fitness in C6/36 cells,
either improves or decreases fitness in the control Vero cell line
and decreases fitness in the bypassed Huh-7 cell line, whereas the
alternating passage either has no effect or predominantly fitness
costs everywhere.
Serial and alternating passage of biologically cloned
DENV
As with the biologically cloned populations passaged in Huh-7
cells, the fitness of cloned viruses passaged in C6/36 cells showed a
general pattern of increase relative to the parent and the fitness of
duplicate lineages was similar (Table 2). Both specialized C6/36
and alternating passages resulted in an increase in fitness in the
C6/36 cell environment, relative to the parent, for the cloned
isolates of both the sylvatic and endemic DENV strains (Figure 5A,
B).
To determine whether fitness increases that occurred in the cell
line used for passage came at the cost of decreased replication in
other cell lines, replication kinetics were also evaluated in the
bypassed cell lines (Huh-7 and Vero). In Huh-7 cells, fitness of
both C6/36 – adapted endemic and sylvatic DENV strains were
significantly lower than those of the alternately passaged viruses
[but the replication kinetics of parent viruses were significantly
lower than both adapted lineages (Figures 5C, D)]. Fitness of both
C6/36 – adapted sylvatic and endemic strains was higher than for
the parents and alternating passage series (except for the endemic
where there was no fitness increase) when their replication was
evaluated in Vero cells (Figure 5E, F). These results indicate that
adaptation to mosquito cells was not entirely cell-specific and are
summarized in Table 2.
Consensus sequence changes of uncloned DENV
The consensus genomic sequences of the 10
th serial passage in
Huh-7 and C6/36 cells, and the final alternating series (which
terminated in Huh-7 cells) were compared to the parental DENV
sequences. In both alternating passage series combined, sylvatic
strain P8-1407 accrued 11 consensus mutations distributed
throughout the genome. Five mutations presented as nucleotide
mixtures (a mixture of two nucleotides, parental and mutant, were
indicated on sequence electropherograms of both cDNA strands)
and 3 of the 11 mutations were synonymous (Table 4). When the
same strain was allowed to specialize in Huh-7 cells for 10
consecutive passages, it accrued 10 consensus mutations, also
distributed throughout the genome, of which 4 were nucleotide
mixtures and 6 were synonymous (Table 4). Endemic strain IQT-
1950 accrued 12 consensus mutations after 10 alternating
passages; five mutations presented as nucleotide mixtures and 6
of the 12 accrued mutations were synonymous (Table 5). When
the same DENV strain was allowed to specialize in Huh-7 cells, it
accrued 10 consensus mutations of which 5 presented as
nucleotide mixture and 5 were synonymous (Table 5).
When either DENV strain was allowed to specialize in C6/36
cells a different mutation distribution emerged. Whereas serial
passages in the vertebrate Huh-7 cell line or alternating passages
between vertebrate and invertebrate cell lines resulted in
mutations distributed throughout the genome (Tables 4 and 5),
serial passage in mosquito cells led to a smaller number of
consensus mutations that were concentrated within the non
structural genes and the 39 – UTR (Table 6).
To eliminate the possibility that mutations in the alternating
passage series occurred at the first transition between invertebrate
and vertebrate cells due to bottleneck events, virus derived from
both cell lines at passage 2 was sequenced. No consensus
mutations were observed at that stage. However when progeny
derived from the 5
th alternating round of replication was
sequenced, a number of mutations that were observed in passage
10 were present (data not shown), suggesting that they were not
due to bottlenecks early on the cyclic transitions from vertebrate
and invertebrate cells but developed over time stochastically or
due to positive selection.
Consensus sequence changes of cloned DENV
Biological clones of both DENV strains were generated by two
rounds of plaque purification on Vero cells and their consensus
sequences were determined. Comparison to the genomic sequenc-
es of the uncloned viruses revealed a number of nucleotide
differences (Table 3). The consensus genomic sequences of the 10
th
serial passage in Huh-7 and C6/36 cells and the final alternating
passage (in Huh-7) were compared to the parental cloned DENV
sequences. Sylvatic strain P8-1407 acquired 5 synonymous
mutations after 10 alternating passages that were distributed
throughout the genome; 2 were nucleotide mixtures and 3 were
synonymous. When strain P8-1407 was allowed to specialize in
Huh-7 cells it also acquired 5 consensus mutations throughout the
genome of which none appeared as nucleotide mixtures and 3
were synonymous. After 10 alternating passages, endemic strain
IQT-1950 accrued 3 consensus mutations of which 2 were
synonymous (Table 7). When the same strain was allowed to
specialize in Huh-7 cells it accrued 4 consensus, non-synonymous
mutations of which 3 presented as nucleotide mixtures (Table 7).
Table 3. Sequence differences between uncloned (parent)
and cloned IQT-1950 and P8-1407 viruses.
DENV strain
Nucleotide changes
during plaque cloning
Amino acid
change
Genome
region/Gene
P8-1407 C2535T - NS1
P8-1407 C4010T SRL NS2A
P8-1407 C4902T - NS3
P8-1407 T6579A - NS4A
P8-1407 T9909C TRN NS5
P8-1407 C9986A - NS5
IQT-1950 C6359T - NS3
IQT-1950 T10392C NA 39 UTR
-=no change; NA=not applicable.
doi:10.1371/journal.ppat.1000467.t003
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resulted in a similar mutation profile as that observed with the
uncloned strains. All mutations were within the nonstructural
genes and 39 – UTR. Specifically, the endemic IQT-1950 strain
developed one consensus, non-synonymous mutation, while the
sylvatic P8-1407 strain accrued 5 consensus mutations of which
one was non-synonymous and one presented as a nucleotide
mixture (Table 8).
Patterns of mutation accumulation and distribution
We compared the accumulation of mutations, measured as the
mean number of total mutations in each passage series in each
virus (N=2 viruses63 passage series=6), in cloned relative to
uncloned populations. Cloned viruses accumulated significantly
fewer mutations than uncloned viruses in the same passage series
(paired t-test, df=5, P=0.002). We therefore considered cloned
and uncloned viruses separately in subsequent analyses.
To evaluate the impact of passage series on mutation
accumulation, we first tested whether the 2 DENV strains used
in the study (P8-1407 and IQT-1950) differed in the number of
mutations following passage. An unpaired t-test using each
passaged virus line (N=6/virus) showed no difference between
viruses in overall number of mutations in either the uncloned
(df=10, P=0.77) or cloned (df=10, P=0.33) populations. We
therefore combined data from the two viruses and used an
ANOVA to compare total number of mutations among passage
series (Table 9). In both uncloned and cloned populations, viruses
passaged in C6/36 cells accumulated fewer mutations than those
passaged in either Huh-7 cells or in alternation. While these
differences were not significant in the cloned population (df=2,
F=2.13, P=0.17), in the uncloned population a significant
difference among passage series was detected (df=2, F=5.4,
P=0.03) and a Tukey-Kramer post-hoc test revealed that viruses
passaged in alternation accumulated significantly more mutations
than viruses passaged exclusively in C6/36 cells (Table 9). This
was particularly striking given that viruses in the alternating
passage series experienced twice as many passages as those
passaged exclusively in either cell line.
Additionally, we assessed the distribution of the 11 non-
synonymous (or non-coding region) mutations that occurred in
more than one passage series, hereafter termed convergent
mutations (Table 10). Several patterns are evident; first, the
number of repetitions of convergent mutations ranged from two to
five. Second, three duplicate passage series (cloned IQT-1950
passaged on C6/36, uncloned IQT-1950 passaged on Huh-7 and
cloned P8-1407 passaged on Huh-7) shared a single convergent
mutation and three duplicate passage series (uncloned IQT-1950
passaged in alternation, uncloned IQT-1950 passaged on C6/36
and uncloned P8-1407 passaged in alternation) shared two
convergent mutations. Third, in one case both the cloned and
uncloned populations of a virus (IQT-1590) shared a single
convergent mutation when passaged exclusively in C6/36 cells.
Table 4. Nucleotide (nt) and amino acid (aa) changes in sequences of alternating and Huh-7 – passaged strain P8-1407 DENV
relative to uncloned parent P8-1407.
Virus Passage
a nt position Region nt change aa change
P8-1407 P10 – A Alt 325 Cap GRR( G / A ) ( A RT)
P8-1407 P10 – B 1120 ENV GRR( G / A ) ( E RK)
P8-1407 P10 – A Alt 1120 ENV GRR( G / A ) ( E RK)
P8-1407 P10 – B Alt 1120 ENV GRAE RK
P8-1407 P10 – B Alt 1405 ENV ARGK RE
P8-1407 P10 – A 1540 ENV GRAE RK
P8-1407 P10 – B 1673 ENV ARW (A/T) (KRM)
P8-1407 P10 – B Alt 2720 NS1 ARG-
P8-1407 P10 – B 2722 NS1 ARR( A / G ) K RE
P8-1407 P10 – B Alt 2739 NS1 CRTK RE
P8-1407 P10 – A 4378 NS2B ARR( A / G ) ( S RG)
P8-1407 P10 – A 4902 NS3 CRT-
P8-1407 P10 – A 6579 NS4A TRA-
P8-1407 P10 – B Alt 7724 NS5 ARCH RP
P8-1407 P10 – B 9179 NS5 GRCG RA
P8-1407 P10 – A Alt 9179 NS5 GRS (G/C) (GRA)
P8-1407 P10 – B Alt 9179 NS5 GRCG RA
P8-1407 P10 – A Alt 9186 NS5 CRY (C/T) -
P8-1407 P10 – A Alt 9276 NS5 CRY (C/T) -
P8-1407 P10 – A Alt 9746 NS5 TRC-
P8-1407 P10 – A 9987 NS5 TRC-
P8-1407 P10 – B 10400 39- UTR TRC-
P8-1407 P10 – A Alt 10400 39- UTR TRC-
P8-1407 P10 – B Alt 10400 39- UTR TRC-
aEach passage was performed in duplicate (series A and B); P10=passage 10; Alt=alternate passage.
doi:10.1371/journal.ppat.1000467.t004
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between viruses passaged in Huh-7 alone and those passaged in
alternation, or between viruses passaged in C6/36 alone and those
passaged in alternation. However no convergent mutations shared
between viruses passaged in Huh-7 alone and C6/36 alone
occurred in the coding region; the two such mutations were
located in the 39 NCR.
Discussion
We hypothesized that DENV evolution is constrained by the
requirement for alternating replication in highly divergent
vertebrate hosts and invertebrate vectors. The trade-off hypothesis
predicts that releasing DENV from alternating host replication by
repeated passages in a single host or cell line (either vertebrate or
invertebrate) will facilitate faster adaptation to that cell line. The
hypothesis also predicts that adaptation to a given host or cell line
will be specific and will result in fitness declines in other hosts or
cell lines. As a consequence of the previous two processes, the
hypothesis predicts that genetic change (particularly nonsynon-
ymous mutations) of virus lines passaged in a single host type will
be more rapid that lines passaged in alternating hosts.
To evaluate these hypotheses, we passaged DENV viruses 10
times, either continuously or alternately, in vertebrate and
invertebrate cells. Moreover, we initiated these passage series with
either genetically homogenous (biologically cloned) virus popula-
tions or heterogeneous, uncloned populations. The consensus
genomic sequences of the experimentally evolved viruses were
determined and their fitness was measured by multicycle
replication kinetics (replication curves) on both the cell type in
which the single-cell line virus had been passaged, as well as in the
bypassed cell line and a novel cell type that had not been used
previously in the experiment.
Our results from uncloned DENV were generally consistent
with the hypothesis that releasing arboviruses from an alternating
replication cycle results in the acquisition of higher fitness for the
retained host cell and loss of fitness in the bypassed cell. Cloned
viruses, in contrast, showed fitness gains in all cell types following
passage, irrespective of the passage regimen. A possible explana-
tion for this discrepancy in the patterns of adaptation in uncloned
and cloned virus populations is the genetic bottleneck effect of the
biological cloning: randomly selected mutations are often
deleterious [55]. Evidence from bacteriophage w6 [56], VSV
[57,58], foot-and-mouth-disease virus (FMDV) [59] and EEEV
[10] suggests that repeated plaque-to-plaque transfers ($40) result
in fitness losses caused by genetic bottlenecks and drift. Although
cloned viruses in this study were subjected to a limited number of
bottleneck events (2 plaque purification events), their consensus
sequences did differ from those of the uncloned viruses, thus the
general increase in fitness that occurred following passage of any
Table 5. Nucleotide (nt) and amino acid (aa) changes in sequences of Huh-7 – passaged IQT-1950 strain DENV relative to uncloned
parent DENV.
Virus Passage
a nt position Region nt change aa change
IQT-1950 P10 – A 506 prM TRY (T/C) -
IQT-1950 P10 – B Alt 978 ENV GRS (G/C) (VRL)
IQT-1950 P10 – A 1119 ENV GRAE RK
IQT-1950 P10 – B 1121 ENV GRA-
IQT-1950 P10 – A Alt 1121 ENV GRR (G/A) -
IQT-1950 P10 – A Alt 1412 ENV TRY (T/C) -
IQT-1950 P10 – A 1539 ENV GRR (G/A) (ERK)
IQT-1950 P10 – B 1539 ENV GRAE RK
IQT-1950 P10 – A Alt 1539 ENV GRAE RK
IQT-1950 P10 – B Alt 1539 ENV GRAE RK
IQT-1950 P10 – B 1657 ENV ARG-
IQT-1950 P10 – B Alt 2014 ENV ARGE RG
IQT-1950 P10 – B Alt 4472 NS2B ARR( A / G ) ( I RM)
IQT-1950 P10 – A 5031 NS3 GRR (G/A) (GRS)
IQT-1950 P10 – B 7083 NS4B ARW (A/T) (MRL)
IQT-1950 P10 – B Alt 7409 NS4B TRC-
IQT-1950 P10 – B 7505 NS4B GRT-
IQT-1950 P10 – A Alt 7505 NS4B GRK (G/T) -
IQT-1950 P10 – B Alt 7514 NS4B TRG-
IQT-1950 P10 – A 7775 NS5 TRY (T/C) -
IQT-1950 P10 – B Alt 8117 NS5 TRC-
IQT-1950 P10 – B Alt 10362 39- UTR ARG-
IQT-1950 P10 – B 10392 39- UTR TRC-
IQT-1950 P10 – A Alt 10392 39- UTR TRC-
IQT-1950 P10 – B Alt 10392 39- UTR TRC-
aEach passage was performed in duplicate (series A and B); P10=passage 10; Alt=alternate passage; -=no change.
doi:10.1371/journal.ppat.1000467.t005
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well as adaptation to specific cell substrates. Previous studies have
indicated that starting fitness can affect RNA virus adaptation
outcomes [51,58,60,61,62,63] and that viruses may acquire both
host cell-specific and amphi-cell-specific adaptations during
passage [64]. Thus, in the following discussion we use only the
data from uncloned viruses to evaluate the predictions of the trade-
off hypothesis for changes in fitness.
The hypothesis that adaptation to a given host cell (Huh-7 or
C6/36) is specific and results in fitness declines in the bypassed cell
Table 7. Nucleotide (nt) and amino acid (aa) changes in sequences of Huh-7 – passaged and alternating-passaged DENV relative
to cloned parent DENV strains.
Virus Passage
a nt position Region nt change aa change
IQT-1950 P10 – A 1539 E GRAE RK
IQT-1950 P10 – B 1539 E GRR (G/A) (ERK)
IQT-1950 P10 – B Alt 1539 E GRAE RK
IQT-1950 P10 – A 2310 E ARW (A/T) (IRL)
IQT-1950 P10 – B 4411 NS2B CRY (C/T) (TRI)
IQT-1950 P10 – B Alt 5348 NS3 ARG-
IQT-1950 P10 – A Alt 6980 NS4B GRT-
IQT-1950 P10 – A 7147 NS4B CRTT RI
P8-1407 P10 – A 228 C ARG-
P8-1407 P10 – B Alt 1905 E ARR (A/G) -
P8-1407 P10 – A 2030 E TRCI RT
P8-1407 P10 – B 2030 E TRCI RT
P8-1407 P10 – A Alt 2883 NS1 ARG-
P8-1407 P10 – A 4707 NS3 ARG-
P8-1407 P10 – A Alt 5974 NS3 TRY (T/C) (CRR)
P8-1407 P10 – B 7385 NS4B CRTT RM
P8-1407 P10 – A 8334 NS5 CRT-
P8-1407 P10 – A Alt 10400 39 –U T R T RC-
P8-1407 P10 – B Alt 10422 39 –U T R G RT-
aEach passage was performed in duplicate (series A and B); P10=passage 10; Alt=alternate passage; -=no change.
doi:10.1371/journal.ppat.1000467.t007
Table 6. Nucleotide (nt) and amino acid (aa) changes in sequences of C6/36-passaged DENV strains relative to uncloned parent
DENV.
Virus Passage
a Cell line nt position Region nt change aa change
IQT-1950 P10 – A C6/36 2906 NS1 ARR (A/G) -
IQT-1950 P10 – A C6/36 4471 NS2B TRCI RT
IQT-1950 P10 – B C6/36 4471 NS2B TRCI RT
IQT-1950 P10 – A C6/36 5144 NS3 TRY (T/C) -
IQT-1950 P10 – A C6/36 7416 NS4B ARGT RA
IQT-1950 P10 – B C6/36 7416 NS4B ARGT RA
IQT-1950 P10 – A C6/36 10392 39-UTR TRY (T/C) -
IQT-1950 P10 – B C6/36 10392 39-UTR TRC-
IQT-1950 P10 – A C6/36 10551 39-UTR GRR (G/A) -
P8-1407 P10 – A C6/36 4902 NS3 CRT-
P8-1407 P10 – B C6/36 4902 NS3 CRY (C/T) -
P8-1407 P10 – A C6/36 6579 NS4A TRA-
P8-1407 P10 – B C6/36 6579 NS4A TRW (T/A) -
P8-1407 P10 – A C6/36 9179 NS5 GRS (G/C) (GRA)
P8-1407 P10 – A C6/36 10560 39-UTR TRC-
aEach passage was performed in duplicate (series A and B). P10=passage 10.
doi:10.1371/journal.ppat.1000467.t006
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predicted, both endemic and sylvatic uncloned viruses allowed to
specialize in Huh-7 or C6/36 cells gained fitness in that cell line.
Also as predicted, viruses passaged in a single cell line lost fitness in
the bypassed cell line. However, fitness increases in the uncloned
sylvatic DENV passaged exclusively in mosquito cells partially
contradicted the tradeoff hypothesis in that fitness also increased in
Vero cells (Table 2). Thus, our Huh-7 or C6/36 cell data are
consistent with the hypothesis that adaptation to a given host or
cell is specific and results in fitness declines in the bypassed cell
line, or in other hosts or cell (Vero cells). However, inconsistent
with the hypothesis, we observed significant fitness increases by
both cloned endemic and sylvatic DENV viruses upon evaluation
in Vero cells. Viruses passaged in alternation showed no change in
fitness on either cell type. Patterns of fitness on a novel cell type
(Vero) were more complex. While passage in Huh-7 cells reliably
led to a decrease in fitness in Vero cells, passage in C6/36 resulted
in variable changes in fitness (increases and decreases).
A third prediction of the trade-off hypothesis is that DENV
passaged in a single host cell type will accrue more mutations in its
consensus sequences, especially nonsynonymous changes, com-
pared to DENV passaged in alternation between two different cell
types. As predicted, viruses passaged in a single host cell line
accumulated more nucleotide and amino acid changes in their
consensus sequences, compared to viruses that replicated in
alternating invertebrate-to-vertebrate host cell passages. Overall,
45% and 50% of the mutations generated within the uncloned and
cloned viruses, respectively, were non-synonymous. Although
these ratios are lower that random expectations, they are
considerably higher than what is observed in nature, where the
vast majority of nucleotide substitutions are synonymous, revealing
purifying selection as the major force shaping arbovirus evolution
[65]. Nonetheless, several non-synonymous mutations occurred in
multiple passage series within the same passage regime and/or
alternate passage regimes, a pattern that strongly suggests
convergent evolution via positive selection. Similar observations
were described previously, where serial passage of DENV-3 in
Vero or C6/36 cells resulted in common amino acid changes that
were repeatedly selected in a given cell passage series [66].
Exclusive DENV passage in vertebrate cells or alternating host
cell passages led to the emergence of a qualitatively and
quantitatively different mutation spectrum than exclusive passage
in mosquito cells. Whereas serial passages in the vertebrate Huh-7
host cell or alternating passages between vertebrate and mosquito
cells resulted mutations distributed throughout the genome, serial
passage in mosquito cells led to mutations located exclusively
within the non-structural protein genes and 39 – UTR. Moreover
the rate of mutation accumulation was significantly slower for
viruses passaged in C6/36 cells than for those passaged in
alternation. These observations support the notion that positive
selection exerts a greater influence within the vertebrate host.
Previous observations by Chen [67] based on similar experiments
and limited consensus sequence of E and NS1 genes provide
further support that mosquito cells have a minimal effect on
DENV evolution. Reverse genetic studies are needed to examine
the contribution of the individual mutations to fitness.
An inherent limitation of utilizing consensus sequences to
monitor evolution of viral populations is that they only reflect the
majority nucleotide at any given position of the viral genome and
do not represent the spectrum of mutations present. Minority
mutant populations, characteristic of RNA virus quasispecies, can
be masked [68]. Our data indicate the presence of mixed
populations at several nucleotide positions. However, it is possible
that other mutations that may also play a role in DENV
adaptation were present (at lower frequencies) but remained
undetected by sequencing of the RT-PCR amplicons. Recent
studies of West Nile (WNV) and St. Louis encephalitis viruses
(SLEV) demonstrate that the diversity of the quasispecies
population can differ in vertebrate hosts and invertebrate vectors
[69,70,71] and that these differences can affect viral virulence
[72]. These studies suggest that viruses passaged in mosquitoes/
mosquito cells gain diversity more rapidly than viruses passaged in
vertebrates/vertebrate cells. Thus, future studies of DENV should
consider the impact of host alternation on the evolution of
quasispecies diversity as well as consensus sequence changes. In
fact, the continued advances in the efficiency, speed and cost of
DNA sequencing including ‘deep sequencing’ can efficiently
sequence a large number of RNA viral genomes. This could
provide complete information on the quasispecies ensemble.
Understanding the forces that shape DENV evolution and the
extent these forces play in the observed shifts to higher virulence in
human infections is important in developing effective counter-
measures, especially in the absence of a licensed vaccine or
antiviral therapies to control the spread of a DENV pandemic.
Methods
Cell cultures
Monolayer cultures of Huh-7 cells (clone JTC-39 obtained from
the Japanese Health Sciences Foundation, Osaka) and Vero cells
(obtained from American Type Culture Collection, Bethesda,
MD) were grown at 37uC in Dulbecco’s minimal essential medium
(DMEM) (4.5 g/L D-Glucose) with 10% heat-inactivated fetal
bovine serum (FBS) and 1% penicillin/streptomycin. C6/36
Table 8. Nucleotide (nt) and amino acid (aa) changes in
sequences of C6/36-passaged DENV relative to cloned parent
DENV strains.
Virus Passage
a nt positionRegion nt change aa change
IQT-1950 P10 – A 4471 NS2B TRY (T/C) (IRT)
IQT-1950 P10 – B 4471 NS2B TRY (T/C) (IRT)
P8-1407 P10 – A 2883 NS1 ARR (A/G) -
P8-1407 P10 – B 5390 NS3 ARGD RG
P8-1407 P10 – B 7305 NS4B CRT-
P8-1407 P10 – A 10400 39- UTR TRC-
P8-1407 P10 – B 10422 39- UTR GRT-
aEach passage was performed in duplicate (series A and B); P10=passage 10; -
=no change.
doi:10.1371/journal.ppat.1000467.t008
Table 9. Overall patterns of DENV mutation accumulation.
Passage Series Total number of mutations6SE
Uncloned viruses Cloned viruses
HuH-7 only 5.2560.25
AB* 2.4560.48
A
Alternating 7.0060.82
A 2.0060.41
A
C6/36 only 3.7560.85
B 1.2660.63
A
*Superscripted letters indicate the results of a Tukey-Kramer post-hoc test.
Uncloned and cloned viruses were analyzed separately. Values that do not
share a letter are significantly different.
doi:10.1371/journal.ppat.1000467.t009
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32uC in Dulbecco’s minimal essential medium (DMEM) (4.5 g/L
D-Glucose) with 10% heat-inactivated FBS, 1% penicillin/
streptomycin and 1% tryptose phosphate broth (TPB).
Viruses and sequencing
To gain insights into potential differences in adaptive constraints
on ancestral and derived lineages of DENV, we utilized two
different strains of DENV-2 in this study: low passage sylvatic P8-
1407 and endemic IQT-1950 DENV-2 (passaged, but uncloned)
strains were obtained from the UTMB World Reference Center for
Emerging Viruses and Arboviruses and amplified once in C6/36
mosquito cells to achieve titers of ,7 log10 focus forming units (ffu)/
ml. Sylvatic P8-1407 was isolated from a sentinel monkey in
Malaysia in 1970 and endemic IQT-1950 was isolated from a
viremic human in Peru in 1995 (see [42] for passage history of
strains). In order to establish homogeneous virus populations for our
study, biological clones of each strain were generated by two rounds
of plaque purification on Vero cells. To ensure at that the ‘picked’
visible clonal DENV populations were not representing a minority
population with unique phenotypic and morphologic characteris-
tics, each visible plaque was marked. Then the agarose plug was
carefully removed without disturbing the monolayer and each
monolayer was fixed with 1 ml of 1:1 methanol:acetone for
20 minutes at room temperature. After removal of the fixative,
the plates were allowed to air-dry, and infected cells were detected
by FFA as described below. Selected clones were representative of
the majority of clones present in the well (Table 11). Each of the
selected cloneswerethenpropagated onceinC6/36cellsinorderto
generate stocks for the passage and replication kinetics studies. Each
virus stock was quantified by FFA assay on C6/36 and Huh-7 cell
lines then aliquoted and stored at 280uC.
Genomic viral RNA (vRNA) was isolated with the Qiagen viral
RNA isolation kit (Qiagen, Valencia). The 59 and 39-t e r m i n u s
sequences of the specific genomes were determined by ligation and
sequencing as described by Mandl et al. [73]. Overlapping cDNA
fragments and amplicons of these viruses were generated using virus-
specific primer pairs and one-step RT-PCR (Roche Diagnostics,
Indianapolis). Amplified sequences were gel purified and automated
sequencing with virus-specific sequencing primers for both strands.
Dengue virus infections
Three different types of passage regimens were performed for
each of the 4 DENV populations (P8-1407 and IQT 1950, cloned
and uncloned): (i) serial, exclusive passage in Huh-7 cells; (ii) serial,
exclusive passage in C6/36 cells; and (iii) alternating passage
between Huh-7 and C6/36 cells. Each strain was passaged in each
regimen in duplicate. Each alternating cycle constituted a round of
DENV infections between C6/36 and Huh-7 cells with Huh-7
being the concluding cell line of the cycle. In order to eliminate
temperature sensitivity as a factor in the outcomes, all infected cell
cultures were incubated at 32uC. Infected cell culture supernatants
were harvested at 4 days post infection to achieve maximum titers.
Cell-free cell culture supernatants were diluted to a multiplicity of
0.01 ffu/ml (based on titers obtained on C6/36 cells) to initiate
subsequent infections. A low multiplicity of infection (MOI) was
maintained to minimize the influence of defective interfering (DI)
particles. To assess variance in outcomes and to identify common
mutations arising due to positive selection, duplicate parallel
passage series were performed for each treatment.
Focus forming assay (FFA)
Ten-fold serial dilutions of virus in MEM supplemented with
2% FBS and antibiotics (Invitrogen, Carlsbad, CA), were
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attached to 24-well CostarH plates and incubated for one hour
with periodic gentle rocking to facilitate virus adsorption at 37uC.
Subsequently, wells were overlaid with 1 ml of 0.8% methylcel-
lulose (Sigma-Aldrich, St. Louis, MO) diluted in warm Optimem
(Invitrogen) supplemented with 2% FBS, antibiotics and 1% (w/v)
L-glutamine, then incubated undisturbed for 4 days at 28uC. The
methylcellulose overlay was then aspirated and cell monolayers
were rinsed once with PBS at pH 7.4 (Invitrogen) then fixed with a
mixture of ice-cold acetone and methanol (1:1) solution and
allowed to incubate for 30 minutes at room temperature. The
fixation solution was aspirated and plates were allowed to air dry.
Plates were washed thrice with PBS supplemented with 3% FBS,
followed by hour-long incubation with a dengue-specific mouse
ascitic fluid. Plates were washed thrice followed by hour-long
incubation with a secondary antibody conjugated to horseradish
peroxide (KPL, Gaithersburg, MD). Detection proceeded with the
addition of AEC substrate (ENZO Diagnostics, Farmingdale, NY)
prepared according to vendor instructions. Antigen stained cells
were counted against a white background and viral titers were
recorded as the reciprocal of the highest dilution where adequate
plaques were detected (greater than 20 but lower than 90) and
expressed as log10focus forming units per ml (ffu/ml).
Replication kinetics
Multistep replication curves were performed to measure virus
fitness in each of three cell types: Vero, mosquito C6/36 or Huh-7.
Because of the large number of samples generated, all replication
curves could not be titered in a single assay. Consequently, a single
virus population passaged serially in one cell type was titered together
with the samepopulation passaged inalternationand with the parent.
For example, P8-1407 (uncloned) that had been passaged only in
Huh-7 cells was titered in the same assay as P8-1407 (uncloned)
passaged in alteration and the parental P8-1407 (uncloned) virus. P8-
1407 (uncloned) that had been passaged only in C6/36 cells was
titered in a separate assay along with P8-1407 (uncloned) passaged in
alterationand the parentalP8-1407(uncloned) virus.Thissubdivision
of assays meant that fitness of viruses passaged only in Huh-7 or C6/
36cellscouldnotbecomparedstatistically(seebelow),alimitationwe
considered acceptable since the question being addressed was
whether virus passaged in a single cell type would differ from virus
passaged in alternation and not whether viruses passaged in different
single cell types differed from each other.
Dishes (30 mm in diameter) containing confluent Vero,
mosquito C6/36 or Huh-7 cell monolayers were prepared and
cell number was determined. Viruses were diluted in MEM
supplemented with 5% FBS, 2 mM L-Glutamine, 1% NEAA, and
50 mg/ml penicillin/streptomycin (Invitrogen), at an MOI of 0.1
ffu/cell (based on titers obtained on C6/36 cells) are infected
simultaneously in triplicate. Infected dishes were incubated for one
hour with periodic gentle rocking to facilitate virus adsorption at
37uC. Viral inocula were removed and cell monolayers were
washed 3 times with PBS to remove un-adsorbed virus. Two ml of
complete cell media (MEM supplemented with 5% FBS, 2 mM L-
Glutamine, 1% NEAA, and 50 mg/ml penicillin/streptomycin)
were then added and cells were incubated at 28uCo r3 7 uC for the
mosquito or mammalian cell lines respectively. At various times (0,
1, 2, 4, and 6 days) post infection, virus from individual dishes
were harvested, purified by low speed centrifugation, and stored at
280uC. Upon completion of the experiment, virus samples
representing the collected time points were assayed by FFA to
determine virus titers. Virus yield at each timepoint was recorded
as log10 ffu/cell, the ratio of the total amount of virus present in
the sample by the number of cells originally infected.
Statistical analysis
Repeated-measures ANOVA [74] was used to compare the
impact of passage regimen on replication curves of each of the four
virus populations in each of three cell types (Vero, Huh-7 and C6/
36). For reasons described above, a given DENV population
serially passaged in a single cell line was compared only to the
matched population passaged in alternation and to the parent. All
comparisons revealed a significant effect of passage regimen
(df=4, P,0.001 for each comparison), a significant effect of day
(df=4, P,0.001 for each comparison), and a significant
interaction between the two factors (df=16, P,0.001 for each
comparison). A Tukey-Kramer post-hoc test was used to detect
differences among passage regimens within each experimental
group. Since this resulted in a large number of comparisons,
conclusions were only drawn from consistent patterns of significant
difference revealed in multiple comparisons.
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